ANGELA KARSTEN: Open Payments
NPI 1851652028 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 26 payments from 15 companies in 2025. Trend: 2023 $1,207 · 2024 $771 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Calyxo, Inc. | 1 | $146 |
| UROGEN PHARMA, INC. | 4 | $100 |
| 180 Medical, Inc. | 2 | $75 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| Boston Scientific Corporation | 2 | $50 |
| Ferring Pharmaceuticals Inc. | 1 | $49 |
| ABBVIE INC. | 2 | $48 |
| TOLMAR, INC. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: CVAC ASPIRATION SYSTEM, KEYTRUDA, ADSTILADRIN, LUPRON DEPOT, JATENZO, Xtandi, LithoVue, JELMYTO.
Industry payments across NE — which companies pay providers there.
